Oxford AstraZeneca

New study claims that efficacy of single dose of Covishield falls after 16 weeks for individuals aged above 60 years

The vaccine is produced by Oxford University and British-Swedish pharmaceutical company AstraZeneca plc.

Covishield to be available in govt hospitals at Rs 400, while in private hospitals at Rs 600

Around 50 per cent of the doses produced by vaccine makers will be provided “in the open market”.

Brazil President thanks PM Modi for ‘Sanjeevani Booti’ against COVID-19

UN offers support as India executes worlds largest COVID-19 vaccination drive

Individuals cannot choose COVID-19 vaccine they prefer, says Health Ministry

Serum Institute in talks to supply 400 million vaccine doses to Gavi-Covax programme

India’s abrupt Covaxin approval draws questions over its efficacy

UK beguns COVID-19 vaccination run, 82-year-old dialysis patient given first shot

India likely to deliver 24 million free COVID-19 vaccine doses to Kenya

India approves Oxford-AstraZeneca and Bharat BioTech’s Covaxin COVID-19 vaccines for emergency use

Oxford-AstraZeneca COVID-19 vaccine ‘Covishield’ probably to get nod by government today